1st Global Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$474K Sell
22,116
-188
-0.8% -$3.79K 0.05% 275
2017
Q1
$382K Buy
22,304
+6,214
+39% +$108K 0.04% 328
2016
Q4
$289K Sell
16,090
-11,148
-41% -$202K 0.04% 385
2016
Q3
$566K Buy
27,238
+2,590
+11% +$64.2K 0.07% 234
2016
Q2
$663K Buy
24,648
+1,466
+6% +$40.2K 0.09% 190
2016
Q1
$628K Buy
23,182
+7,482
+48% +$200K 0.09% 201
2015
Q4
$456K Buy
15,700
+760
+5% +$21K 0.07% 224
2015
Q3
$405K Buy
14,940
+714
+5% +$20.2K 0.06% 244
2015
Q2
$389 Sell
14,226
-458
-3% -$12.9K 0.06% 258
2015
Q1
$392K Sell
14,684
-4,028
-22% -$92.8K 0.06% 263
2014
Q4
$396K Buy
18,712
+1,126
+6% +$25.2K 0.06% 248
2014
Q3
$419K Buy
17,586
+842
+5% +$19.4K 0.07% 230
2014
Q2
$387K Buy
16,744
+7,734
+86% +$171K 0.06% 248
2014
Q1
$206K Buy
+9,010
New +$192K 0.04% 384

Other funds holding NVO

1st Global Advisors's NVO Position: Q2 2017 in Review

1st Global Advisors reduced its Novo Nordisk (NVO) stake by 0.84% in Q2 2017, selling an estimated $3.79K and leaving 22,116 shares worth $474K. The position accounts for 0.05% of the portfolio, ranked #275.

1st Global Advisors first reported a position in NVO in Q1 2014 and has held it in 14 quarters since. The position peaked at $663K in Q2 2016. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • 1st Global Advisors held 22,116 shares of Novo Nordisk worth $474K as of Q2 2017.
  • 1st Global Advisors sold 188 Novo Nordisk shares in Q2 2017, an estimated $3.79K.
  • Novo Nordisk made up 0.05% of 1st Global Advisors's portfolio in Q2 2017, its #275 holding.
  • 1st Global Advisors first reported a position in Novo Nordisk in Q1 2014 and has held it in 14 quarters since.
  • 1st Global Advisors's Novo Nordisk position peaked at $663K in Q2 2016.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.